The funding will support production scale-up and market entry for the company's carbon-based agricultural biostimulants.
"We are thrilled with this new, exciting stage for Glaia. Many climate friendly technologies tackle the issue of emissions directly – but we decided to approach the problem from the other direction. What if we could improve current productivity without increasing the carbon footprint?"
The second close of the Series A round was joined by participants including Lockheed Martin, In-Q-Tel, and Contrarian Ventures.
"We are thrilled to have raised further funding to propel our expansion into the US market. Our advanced thermal infrared camera will be able to offer unique, previously unseen insights into human activity and the full constellation will enable up to twenty revisits per day of a single location anywhere on the planet. The funding supports the development of new applications and enables closer collaboration on proof of concepts with our customers. This investment further demonstrates that our technology offers potential benefits for national security capabilities, and we look forward to building and expanding our relationship with partners overseas, particularly the US."